http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106755461-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate | 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106755461-B |
| titleOfInvention | With the associated interleukin 21 of primary biliary cholangitis and its application |
| abstract | The present invention discloses application of the interleukin 21 (IL21) in the product of preparation detection or auxiliary detection, screening or prediction primary biliary cholangitis (Primary Biliary Cholangitis, PBC).Invention additionally discloses to the mononucleotide polymorphic site of the significant relevant interleukin 21 of primary biliary cholangitis neurological susceptibility are as follows: rs17005934, rs17005953, rs28517551, rs925550, rs60318098, rs1026157, rs6811183.Present invention firstly discovers that multiple gene polymorphism sites of IL21 are significant related to the generation of PBC, it can be used for one of the index of PBC onset risk prediction. |
| priorityDate | 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.